Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Parkinson's Disease-Associated LRRK2 Hyperactive Kinase Mutant Disrupts Synaptic Vesicle Trafficking in Ventral Midbrain Neurons
Ping‐Yue Pan, Xianting Li, Jing Wang, et al.
Journal of Neuroscience (2017) Vol. 37, Iss. 47, pp. 11366-11376
Open Access | Times Cited: 128

Showing 1-25 of 128 citing articles:

Autophagy in Parkinson's Disease
Xu Hou, Jens O. Watzlawik, Fabienne C. Fiesel, et al.
Journal of Molecular Biology (2020) Vol. 432, Iss. 8, pp. 2651-2672
Open Access | Times Cited: 282
Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson’s Disease
Maria Nguyen, Yvette C. Wong, Daniel Ysselstein, et al.
Trends in Neurosciences (2018) Vol. 42, Iss. 2, pp. 140-149
Open Access | Times Cited: 271
Excitotoxicity, calcium and mitochondria: a triad in synaptic neurodegeneration
Manish Verma, Britney N. Lizama, Charleen T. Chu
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 268
Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease
Xiansi Zeng, Wen-Shuo Geng, Jing Jia, et al.
Frontiers in Aging Neuroscience (2018) Vol. 10
Open Access | Times Cited: 178
Cell biology of Parkinson's disease: Mechanisms of synaptic, lysosomal, and mitochondrial dysfunction
Sarah M. Brooker, G Naylor, Dimitri Krainc
Current Opinion in Neurobiology (2024) Vol. 85, pp. 102841-102841
Closed Access | Times Cited: 26
LRRK2 Biology from structure to dysfunction: research progresses, but the themes remain the same
Daniel C. Berwick, George R. Heaton, Sonia Azeggagh, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 146
Role of the endolysosomal system in Parkinson’s disease
D. J. Vidyadhara, John E. Lee, Sreeganga S. Chandra
Journal of Neurochemistry (2019) Vol. 150, Iss. 5, pp. 487-506
Open Access | Times Cited: 125
“LRRK2: Autophagy and Lysosomal Activity”
Marta Madureira, Natalie Connor‐Robson, Richard Wade‐Martins
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 114
Autophagy lysosomal pathway dysfunction in Parkinson's disease; evidence from human genetics
Konstantin Senkevich, Ziv Gan‐Or
Parkinsonism & Related Disorders (2019) Vol. 73, pp. 60-71
Open Access | Times Cited: 109
Parkinson's disease: convergence on synaptic homeostasis
Sandra‐Fausia Soukup, Roeland Vanhauwaert, Patrik Verstreken
The EMBO Journal (2018) Vol. 37, Iss. 18
Open Access | Times Cited: 107
The landscape of multiscale transcriptomic networks and key regulators in Parkinson’s disease
Qian Wang, Yuanxi Zhang, Minghui Wang, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 100
Disease model organism for Parkinson disease: Drosophila melanogaster
Binod Aryal, Youngseok Lee
BMB Reports (2019) Vol. 52, Iss. 4, pp. 250-258
Open Access | Times Cited: 95
Neuronal vulnerability in Parkinson disease: Should the focus be on axons and synaptic terminals?
Yvette C. Wong, Kelvin C. Luk, Kerry Purtell, et al.
Movement Disorders (2019) Vol. 34, Iss. 10, pp. 1406-1422
Open Access | Times Cited: 91
LRRK2 and the Endolysosomal System in Parkinson’s Disease
Madalynn L. Erb, Darren J. Moore
Journal of Parkinson s Disease (2020) Vol. 10, Iss. 4, pp. 1271-1291
Open Access | Times Cited: 82
Molecular Mechanisms Underlying Synaptic and Axon Degeneration in Parkinson’s Disease
Nolwazi Z. Gcwensa, Drèson L. Russell, Rita M. Cowell, et al.
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 71
LRRK2 suppresses lysosome degradative activity in macrophages and microglia through MiT-TFE transcription factor inhibition
Narayana Yadavalli, Shawn M. Ferguson
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 31
Open Access | Times Cited: 33
LRRK2 in Drosophila Melanogaster Model: Insights into Cellular Dysfunction and Neuroinflammation in Parkinson’s Disease
Cristina Ciampelli, Grazia Galleri, Manuela Galioto, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2093-2093
Open Access | Times Cited: 1
Anti-Parkinson Potential of Silymarin: Mechanistic Insight and Therapeutic Standing
Hammad Ullah, Haroon Khan
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 79
Parkinson's Disease-Linked LRRK2-G2019S Mutation Alters Synaptic Plasticity and Promotes Resilience to Chronic Social Stress in Young Adulthood
Bridget A. Matikainen‐Ankney, Nebojsa Kezunovic, Caroline Ménard, et al.
Journal of Neuroscience (2018) Vol. 38, Iss. 45, pp. 9700-9711
Open Access | Times Cited: 60
Parkinson’s Disease-Related Genes and Lipid Alteration
Milena Fais, Antonio Dore, Manuela Galioto, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7630-7630
Open Access | Times Cited: 43
Estrogen plays an important role by influencing the NLRP3 inflammasome
Wanglin Dong, Qianwen Peng, Z. Liu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115554-115554
Open Access | Times Cited: 19
Advancements in Genetic and Biochemical Insights: Unraveling the Etiopathogenesis of Neurodegeneration in Parkinson’s Disease
Yashumati Ratan, Aishwarya Rajput, Ashutosh Pareek, et al.
Biomolecules (2024) Vol. 14, Iss. 1, pp. 73-73
Open Access | Times Cited: 8
Neurodevelopmental and synaptic defects in DNAJC6 parkinsonism, amenable to gene therapy
Lucia Abela, Lorita Gianfrancesco, Erica Tagliatti, et al.
Brain (2024) Vol. 147, Iss. 6, pp. 2023-2037
Open Access | Times Cited: 8
LRRK2 kinase inhibition protects against Parkinson's disease-associated environmental toxicants
Neda M. Ilieva, Eric K. Hoffman, Mohammed Ghalib, et al.
Neurobiology of Disease (2024) Vol. 196, pp. 106522-106522
Open Access | Times Cited: 8
LRRK2 in Parkinson's disease: upstream regulation and therapeutic targeting
Yulan Xiong, Jianzhong Yu
Trends in Molecular Medicine (2024) Vol. 30, Iss. 10, pp. 982-996
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top